Systematic evaluation of variability in ChIP-chip experiments using predefined DNA targetsDavid S. Johnson, X. Shirley Liu, Wei Li et al.|Genome Research|2008Cited by 129
Avelumab maintenance in advanced urothelial carcinoma: biomarker analysis of the phase 3 JAVELIN Bladder 100 trialThomas Powles, Craig B. Davis, Jie Pu et al.|Nature Medicine|2021Cited by 115
An Engineered IL15 Cytokine Mutein Fused to an Anti-PD1 Improves Intratumoral T-cell Function and Antitumor ImmunityYuanming Xu, Javier Chaparro‐Riggers, Lucia Campos Carrascosa et al.|Cancer Immunology Research|2021Cited by 98